摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6R)-6-methyltetrahydropyran-2-ol | 194795-88-5

中文名称
——
中文别名
——
英文名称
(6R)-6-methyltetrahydropyran-2-ol
英文别名
(R)-6-methyl δ-lactol;(6R)-6-methyloxan-2-ol
(6R)-6-methyltetrahydropyran-2-ol化学式
CAS
194795-88-5
化学式
C6H12O2
mdl
——
分子量
116.16
InChiKey
XCNWVNNDBZRDEA-LWOQYNTDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    180.2±8.0 °C(Predicted)
  • 密度:
    1.014±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (6R)-6-methyltetrahydropyran-2-olsodium hexamethyldisilazane 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 40.5h, 生成 ((S)-1-Dimethylcarbamoyl-ethyl)-((2R,6R)-6-methyl-tetrahydro-pyran-2-yl)-carbamic acid tert-butyl ester
    参考文献:
    名称:
    6-Methyl δ-lactol derived chiral glycine equivalents for the asymmetric synthesis of protected α-amino amides
    摘要:
    Two new delta-lactol derived chiral glycine equivalents have been prepared in one-pot processes in good yields from the known 6-methyltetrahydropyran-2-ol. Alkylation proceeds in moderate to good yields and moderate to good selectivities under experimentally simple conditions. The lactol chiral auxiliary is readily removed under mild acidic conditions to give N-Cbz protected alpha-amino amides in good yields. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2004.01.026
  • 作为产物:
    描述:
    参考文献:
    名称:
    Biocatalyst-Mediated Efficient Preparation of Highly Enantiomerically Enriched (R)-5-Hexanolide
    摘要:
    本文描述了生物催化剂介导的高效制备高对映体富集度的(R)-5-己内酯(1)的方法。通过Yamadazyma farinosa IFO 10896对5-氧代己酸的对映选择性还原,随后经脂酶催化的动力学拆分,得到了产率为62%、对映体过量值高达99.7%的(R)-1。
    DOI:
    10.1055/s-1997-972
点击查看最新优质反应信息

文献信息

  • Origin of Diastereocontrol in the Oxy-Michael Reactions of δ-Lactol Anions: A Computational and Experimental Study
    作者:Robert D. Richardson、Felix A. Hernandez-Juan、John W. Ward、Darren J. Dixon
    DOI:10.1002/chem.200801368
    日期:2008.10.29
    energy refinements. The resulting proposed model for the origins of stereocontrol in this reaction has been tested by experiment. The reactions lead to a high cis diastereoselectivity across the THP ring due to the preference for both the alkoxide and the 6-substituent to sit equatorial in the alkylation transition structure. In the oxy-Michael addition of these lactolates to beta-substituted nitroolefins
    通过从头算(MP2)能量优化的密度泛函(B3LYP)计算,研究了“裸” 6-取代的δ-乳酸酯的烷基化和迈克尔加成中的非对映选择性。已经通过实验测试了所提出的用于该反应中立体控制起源的模型。由于偏爱醇盐和6-取代基都位于烷基化过渡结构中的赤道,该反应导致整个THP环具有很高的顺式非对映选择性。在将这些乳酸酯的氧基-迈克尔加成到β-取代的硝基烯烃中时,我们提出对硝基的高非对映选择性β-是空间,立体电子和溶剂化因子结合的结果。
  • CONJUGATES OF IMMUNE CELL SPECIFIC MACROLIDE COMPOUNDS WITH ANTI-INFLAMMATORY COMPOUNDS FOR IMPROVED CELLULAR TARGETING OF ANTI-INFLAMMATORY THERAPY
    申请人:GlaxoSmithKline istrazivacki centar Zagreb d.o.o.
    公开号:EP1351973B1
    公开(公告)日:2010-03-31
  • ENZYMATIC SYNTHESIS OF ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATES THEREOF
    申请人:LEK Pharmaceuticals d.d.
    公开号:EP2655650B1
    公开(公告)日:2017-12-20
  • BIOCONJUGATES OF HETEROCYCLIC COMPOUNDS
    申请人:Hao Xiujuan
    公开号:US20190339283A1
    公开(公告)日:2019-11-07
    The invention provides bioconjugates of heterocylic compounds such as S-adenosylmethionine and S-adenosylhomocysteine with biotin or digoxigenin. The bioconjugates also include carbon and nitrogen linker moieties of varying length that are used to attach such compounds to biotin or digoxigenin. The conjugates are useful in immunoassays. The invention provides a method for detecting SAM and SAH, comprising the steps of: (a) preparing the following components: (i) bio-conjugates of SAM, SAM analogs or SAH; (ii) an europium, a terbium cryptate or other fluorophore as a donor that has a specific ligand for the tracer in the bio-conjugates of (i); (iii) an acceptor fluorescent dye that has the excitation spectra overlap those of donor's emissions and has an antibody specific for SAM or SAH labeled; (b) addition of the biological fluid containing said SAM or SAH; and (c) spectroscopic measurement of the fluorescence of the donor and the fluorescence of from the acceptor.
  • [EN] MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS MACROLIDES ET PROCÉDÉS POUR LEUR FABRICATION ET LEUR UTILISATION
    申请人:RIB X PHARMACEUTICALS INC
    公开号:WO2008143729A2
    公开(公告)日:2008-11-27
    [EN] The present invention provides a family of branched amide containing macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, antiproliferative, anti-inflammatory, and prokinetic agents.
    [FR] La présente invention concerne une famille d'amide ramifiée contenant des composés macrocycliques utiles comme agents thérapeutiques. En particulier, ces composés sont utiles comme agents anti-infectieux, anti-prolifération, anti-inflammatoire et procinétiques.
查看更多

同类化合物

(3S,4R)-3-氟四氢-2H-吡喃-4-胺 鲁比前列素中间体 顺-4-(四氢吡喃-2-氧)-2-丁烯-1-醇 顺-3-Boc-氨基-四氢吡喃-4-羧酸 锡烷,三丁基[3-[(四氢-2H-吡喃-2-基)氧代]-1-炔丙基]- 蒜味伞醇B 蒜味伞醇A 茉莉吡喃 苄基2,3-二-O-乙酰基-4-脱氧-4-C-硝基亚甲基-β-D-阿拉伯吡喃果糖苷 膜质菊内酯 红没药醇氧化物A 科立内酯 甲磺酸酯-四聚乙二醇-四氢吡喃醚 甲基[(噁烷-3-基)甲基]胺 甲基6-氧杂双环[3.1.0]己烷-2-羧酸酯 甲基4-脱氧吡喃己糖苷 甲基2,4,6-三脱氧-2,4-二-C-甲基吡喃葡己糖苷 甲基1,2-环戊烯环氧物 甲基-[2-吡咯烷-1-基-1-(四氢-吡喃-4-基)-乙基]-胺 甲基-(四氢吡喃-4-甲基)胺 甲基-(四氢吡喃-2-甲基)胺盐酸盐 甲基-(四氢吡喃-2-甲基)胺 甲基-(四氢-吡喃-3-基-胺 甲基-(四氢-吡喃-3-基)-胺盐酸盐 甲基-(4-吡咯烷-1-甲基四氢吡喃-4-基)-胺 甲基(5R)-3,4-二脱氧-4-氟-5-甲基-alpha-D-赤式-吡喃戊糖苷 环氧乙烷-2-醇乙酸酯 环己酮,6-[(丁基硫代)亚甲基]-2,2-二甲基-3-[(四氢-2H-吡喃-2-基)氧代]-,(3S)- 环丙基-(四氢-吡喃-4-基)-胺 玫瑰醚 独一味素B 溴-六聚乙二醇-四氢吡喃醚 氯菊素 氯丹环氧化物 氨甲酸,[[(四氢-2H-吡喃-2-基)氧代]甲基]-,乙基酯 氧化氯丹 正-(四氢-4-苯基-2h-吡喃-4-基)乙酰胺 次甲霉素 A 桉叶油醇 抗-11-氧杂三环[4.3.1.12,5]十一碳-3-烯-10-酮 戊二酸二甲酯 恩洛铂 异丙基-(四氢吡喃-4-基)胺 四氢吡喃醚-二聚乙二醇 四氢吡喃酮 四氢吡喃-4-醇 四氢吡喃-4-肼二盐酸盐 四氢吡喃-4-羧酸甲酯 四氢吡喃-4-羧酸噻吩酯